Gilead Sciences reported $63.17B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
ALKERMES ALKS:US USD 1.94B 15.52M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 65.12B 1.42B
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Coherus Biosciences CHRS:US USD 550.91M 4.9M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Moderna Inc MRNA:US USD 26.06B 13M
Novartis NOVN:VX USD 118.46B 4.45B
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Puma Biotechnology PBYI:US USD 198.77M 5.12M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
United Therapeutics UTHR:US USD 5.78B 238.3M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
YTE INCY:US USD 5.51B 191.18M